Securities Registration: Employee Benefit Plan (s-8)
24 Marzo 2022 - 3:31PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on March 24, 2022
Registration
No. 333-
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
RENOVACOR, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
Delaware |
|
83-3169838 |
(State or other jurisdiction of
incorporation or organization) |
|
(IRS Employer
Identification No.) |
P.O. Box 8142
Greenwich, Connecticut 06836
(610) 424-2650
(Address, including zip code, of Principal Executive Offices)
RENOVACOR, INC. 2021 OMNIBUS INCENTIVE PLAN
(Full title of the plan)
|
|
|
|
|
Copies to: |
Magdalene Cook, M.D.
President and Chief Executive Officer
Renovacor, Inc. P.O. Box
8142 Greenwich, Connecticut 06836
(610) 424-2650 |
|
Rachael M. Bushey, Esq.
Troutman Pepper Hamilton Sanders LLP
3000 Two Logan Square
Eighteenth and Arch Streets
Philadelphia, PA 19103
(215) 981-4331 |
(Name, address and telephone number of agent for service) |
|
|
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
|
|
|
|
Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☒ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement is being filed for the purpose of registering an additional 779,396 shares of Common Stock of Renovacor, Inc. (the
Registrant) that were added to the shares authorized for issuance under the Renovacor, Inc. 2021 Omnibus Incentive Plan (the 2021 Plan) for which a Registration Statement on Form
S-8 relating to the same employee benefit plan is effective.
The Registrant previously filed a Registration
Statement on Form S-8 (File No. 333-261054) with the Securities and Exchange Commission (the Commission) to register 2,229,407 shares of common
stock, par value $0.0001 per share (Common Stock) that were authorized for issuance under the 2021 Plan. Upon the effectiveness of this Registration Statement, an aggregate of 3,008,803 shares of Common Stock will be registered
for issuance from time to time under the 2021 Plan. Pursuant to General Instruction E to Form S-8, the contents of the Registration Statement on Form S-8 (File No. 333-261054) filed with the Commission on November 12, 2021 are incorporated herein by reference except to the extent supplemented, amended or superseded by the information set forth herein. Only those
items of Form S-8 containing new information not contained in the earlier registration statements are presented herein.
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The information specified in Part I of Form S-8 is omitted from this filing in accordance with the provisions of Rule
428 under the Securities Act and the introductory note to Part I of the Form S-8 instructions. The documents containing the information specified in Part I will be delivered to the participants in the 2021
Plan as required by Rule 428(b)(1) under the Securities Act of 1933 (the Securities Act).
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, which have been filed by the Registrant with the Commission pursuant to the Securities Act and the Exchange Act of 1934, as amended
(the Exchange Act), are incorporated by reference in, and shall be deemed to be a part of, this Registration Statement as of their respective dates:
|
(a) |
The Registrants Annual Report on Form
10-K for the fiscal year ended December 31, 2021 (as filed with the Commission on March 24, 2022); |
|
(b) |
The Registrants Current Report on Form
8-K filed on March 2, 2022; and |
|
(c) |
The description of the Registrants common stock contained in Exhibit
4.5 of the Registrants Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (as filed with the Commission on March 24, 2022), including any amendment or report filed for the
purpose of further updating such description. |
All reports and other documents filed by the Registrant with the Commission pursuant to
Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (other than information furnished under Item 2.02 or 7.01 of Form 8-K and exhibits furnished on such form that relate to such items unless such form
expressly provides to the contrary) after the date hereof and prior to the filing of a post-effective amendment which indicates that all securities offered pursuant to this Registration Statement have been sold or which deregisters all securities
then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents or reports.
For purposes of this Registration Statement, any document or any statement contained in a document incorporated or deemed to be incorporated herein by
reference shall be deemed to be modified or superseded to the extent that a subsequently filed document or a statement contained therein, or in any other subsequently filed document which also is or is deemed to be incorporated by reference,
modifies or supersedes such document or such statement in such document. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 8. Exhibits.
The following documents are filed
as exhibits to this Registration Statement:
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Greenwich, State of Connecticut on
March 24, 2022.
|
|
|
RENOVACOR, INC. |
|
|
By: |
|
/s/ Magdalene Cook, M.D. |
|
|
Magdalene Cook, M.D. |
|
|
President and Chief Executive Officer |
|
|
(Principal Executive Officer) |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Magdalene Cook, M.D. and Wendy
DiCicco, and each of them, as his or her true and lawful attorney-in-fact and agent with full power of substitution, for him or her in any and all capacities, to sign
any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact, proxy, and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully
for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact, proxy and agent, or his or her
substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, this Registration Statement has
been signed by the following persons in the capacities and on the dates indicated.
|
|
|
|
|
Signature |
|
Title |
|
Date |
|
|
|
/s/ Magdalene Cook, M.D.
Magdalene Cook, M.D. |
|
Chief Executive Officer, President and
Chairperson of the Board
(Principal Executive Officer) |
|
March 24, 2022 |
|
|
|
/s/ Wendy DiCicco
Wendy DiCicco |
|
Interim Chief Financial Officer
(Principal Financial and Accounting Officer) |
|
March 24, 2022 |
|
|
|
/s/ Gbola Amusa, M.D.
Gbola Amusa, M.D. |
|
Director |
|
March 24, 2022 |
|
|
|
/s/ Edward J. Benz, Jr., M.D.
Edward J. Benz, Jr., M.D. |
|
Director |
|
March 24, 2022 |
|
|
|
/s/ Gregory F. Covino
Gregory F. Covino |
|
Director |
|
March 24, 2022 |
|
|
|
/s/ Jonas Grossman
Jonas Grossman |
|
Director |
|
March 24, 2022 |
|
|
|
/s/ Joan Lau, Ph.D.
Joan Lau, Ph.D. |
|
Director |
|
March 24, 2022 |
|
|
|
/s/ Thomas Needham |
|
Director |
|
March 24, 2022 |
Thomas Needham |
|
|
|
|
Renovacor (AMEX:RCOR)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Renovacor (AMEX:RCOR)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
Real-Time news about Renovacor Inc (American Stock Exchange): 0 recent articles
Más de Renovacor, Inc. Artículos de Noticias